What is Prazepam
NOTE: This drug is discontinued in the US.
NOTE: Prazepam is a schedule C-IV controlled substance.
Prazepam is an oral benzodiazepine used for the management of symptoms associated with anxiety disorders and for short-term amelioration of the symptoms of anxiety or anxiety associated with depression.
Shorter-duration benzodiazepines are often preferable to prazepam in the treatment of anxiety, particularly in the elderly or patients with liver disease, because prazepam produces an active metabolite with a prolonged half-life. Prazepam was approved by the FDA in 1976.
The Centrax® product was discontinued by the manufacturer in 1996; the FDA subsequently withdrew the NDA for this drug after market removal.
For the treatment of anxiety
- physiological dependence
- psychological dependence
- laboratory monitoring not necessary
- abrupt discontinuation
- benzodiazepine dependence
- benzodiazepine hypersensitivity
- hepatic disease
- myasthenia gravis
- Parkinson’s disease
- pulmonary disease
- renal failure
- renal impairment
- respiratory depression
- sleep apnea
- substance abuse
- suicidal ideation
No information is available regarding drug interactions associated with Prazepam